2016 annual financial data
Alnylam Pharmaceuticals 2016 Operating margin
Alnylam Pharmaceuticals 2016 operating margin with verified reported values.
Direct answer
Operating margin was -900.33%.
Operating income was -424,587,000 USD and net income was -410,108,000 USD.
Operating cash flow was -307,701,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,159,000 USD
- Operating income
- -424,587,000 USD
- Net income
- -410,108,000 USD
- Operating cash flow
- -307,701,000 USD